Here, we explain a pharmacogenetics technique which allows to selectively and reversibly inactivate LC neurons using Designer Receptors Completely Activated by Designer Medicines (DREADD). We show the expression on the hM4Di DREADD is usually restricted to noradrenergic LC neurons and that the quantity of LC inhibition is often altered by https://zachc170ixh8.oneworldwiki.com/user